Affordable Access

[Cardiovascular morbidity/mortality modified by the use of FGE1 alpha-cyclodextran and calcium heparin in patients with severe vascular diseases].

Authors
Type
Published Article
Journal
Minerva cardioangiologica
Publication Date
Volume
46
Issue
10 Suppl 1
Pages
55–58
Identifiers
PMID: 10658446
Source
Medline
License
Unknown

Abstract

Cyclic treatment with PGE1 alpha-ciclodestrina produces an important decrease in cardiovascular morbidity and mortality which could be further reduced by the chronic use of subcutaneous calcium heparin.

Statistics

Seen <100 times